bioMérieux Logo

bioMérieux

ISIN

FR0013280286

Ticker

BIM

Sector

Health Care

Sub-Industry

Health Care Equipment

Country

France

Year Founded

1963

About bioMérieux

Company Description

Dedicated to solving some of today’s biggest public health challenges, bioMérieux has the focus and the capabilities to discover, develop, and commercialize advanced medical diagnostics solutions that have an impact on people’s lives. We combine the dynamism of a technology-fueled company with the long-term thinking of our founding family. It is this alliance that shapes our strategy and success.

A values-based company, we aim for strong and sustainable performance that benefits our shareholders, our employees, and society.

Headcount

10,400

Served Area

Worldwide

Headquarters

376 Chemin de l'Orme
69280, Marcy l'Etoile
France

Financial statements

Download as Excel
Line item in (eur) 01.01.2021 01.01.2022 01.01.2023
Assets 3,927,800,000.00 4,605,000,000.00 5,186,600,000.00
Noncurrent Assets 2,266,300,000.00 2,412,500,000.00 2,969,900,000.00
Property Plant And Equipment 939,000,000.00 1,100,800,000.00 1,250,300,000.00
Goodwill 629,400,000.00 669,500,000.00 812,500,000.00
Intangible Assets Other Than Goodwill 430,700,000.00 411,500,000.00 625,000,000.00
Investment Accounted For Using Equity Method 0.00 900,000.00 900,000.00
Deferred Tax Assets 72,600,000.00 32,000,000.00 58,700,000.00
Noncurrent Finance Lease Receivables 14,300,000.00 12,600,000.00 12,900,000.00
Current Assets 1,661,600,000.00 2,184,600,000.00 2,216,700,000.00
Other Current Receivables 82,200,000.00 117,800,000.00 152,600,000.00
Cash and cash equivalents 389,200,000.00 803,500,000.00 552,600,000.00
Noncurrent Assets Or Disposal Groups Classified As Held For Sale 0.00 8,000,000.00 0.00
Other Current Assets 8,000,000.00 9,500,000.00 16,300,000.00
Equity And Liabilities 3,927,800,000.00 4,605,000,000.00 5,186,600,000.00
Equity 2,481,300,000.00 3,163,600,000.00 3,642,900,000.00
Issued Capital 12,000,000.00 12,000,000.00 12,000,000.00
Retained Earnings Profit Loss For Reporting Period 404,400,000.00 601,100,000.00 452,400,000.00
Share Premium N/A 63,700,000.00 74,000,000.00
Other Reserves N/A 1,211,100,000.00 1,094.00
Equity Attributable To Owners Of Parent 2,431,100,000.00 3,112,200,000.00 3,604,200,000.00
Noncontrolling Interests 50,200,000.00 51,400,000.00 38,700,000.00
Noncurrent Liabilities 522,700,000.00 485,600,000.00 412,500,000.00
Noncurrent Provisions 64,400,000.00 62,500,000.00 41,100,000.00
Deferred Tax Liabilities 105,800,000.00 60,300,000.00 53,000,000.00
Current Liabilities 923,800,000.00 955,800,000.00 1,131,100,000.00
Current Provisions 51,400,000.00 51,500,000.00 42,100,000.00
Other Current Payables 451,700,000.00 448,500,000.00 507,900,000.00
Liabilities Included In Disposal Groups Classified As Held For Sale 0.00 0.00 0.00
Line item in (eur) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 3,118,200,000.00 3,376,200,000.00 3,589,100,000.00
Profit Loss From Operating Activities 552,800,000.00 784,300,000.00 587,200,000.00
Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method -200,000.00 -700,000.00 0.00
Income Tax Expense Continuing Operations 121,500,000.00 175,600,000.00 140,100,000.00
Profit (loss) 402,700,000.00 598,200,000.00 440,500,000.00
Profit Loss Attributable To Owners Of Parent 404,400,000.00 601,100,000.00 452,400,000.00
Profit Loss Attributable To Noncontrolling Interests -1,700,000.00 -2,900,000.00 -11,800,000.00
Line item in (eur) 01.01.2021 01.01.2022 01.01.2023
Profit (loss) 402,700,000.00 598,200,000.00 440,500,000.00
Adjustments For Income Tax Expense -121,500,000.00 -175,600,000.00 -140,100,000.00
Adjustments For Decrease Increase In Inventories 82,900,000.00 48,800,000.00 92,100,000.00
Adjustments For Decrease Increase In Other Operating Receivables -500,000.00 -2,700,000.00 -500,000.00
Adjustments For Increase Decrease In Trade Account Payable -4,700,000.00 -24,200,000.00 -9,900,000.00
Adjustments For Depreciation And Amortisation Expense -210,800,000.00 -189,000,000.00 -210,000,000.00
Adjustments For Provisions 16,300,000.00 -2,300,000.00 -17,000,000.00
Adjustments For Sharebased Payments 9,900,000.00 12,400,000.00 13,000,000.00
Adjustments For Fair Value Gains Losses 600,000.00 400,000.00 900,000.00
Adjustments For Undistributed Profits Of Associates 200,000.00 700,000.00 0.00
Other Adjustments To Reconcile Profit Loss -19,100,000.00 7,700,000.00 -11,600,000.00
Income Taxes Paid Refund Classified As Operating Activities -115,900,000.00 -185,400,000.00 -223,500,000.00
Cash Flows From Used In Operating Activities 582,800,000.00 824,700,000.00 475,100,000.00
Cash Flows From Used In Investing Activities -265,200,000.00 -307,300,000.00 -528,100,000.00
Payments To Acquire Or Redeem Entitys Shares 18,400,000.00 17,400,000.00 157,200,000.00
Proceeds From Borrowings Classified As Financing Activities 292,000,000.00 18,200,000.00 67,700,000.00
Repayments Of Borrowings Classified As Financing Activities 426,500,000.00 68,300,000.00 53,400,000.00
Cash Flows From Used In Financing Activities -176,200,000.00 -140,600,000.00 -244,200,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A 376,800,000.00 -297,200,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents -34,100,000.00 39,200,000.00 38,700,000.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes 141,400,000.00 376,800,000.00 N/A
Cash and cash equivalents 389,200,000.00 803,500,000.00 552,600,000.00

Please note that some sums might not add up.

Filings & Publications

  • Consolidated Report 2022 - Q4 French 🇫🇷
  • Consolidated Report 2021 - Q4 French 🇫🇷
  • Consolidated Report 2020 - Q4 French 🇫🇷

Insider Trades

Date Trading entity / Person Association Trade type Volume
04.09.2023 None Other Sell EUR 137,517.82
04.09.2023 None Other Sell EUR 120,328.10
01.09.2023 None Other Other EUR 0.00
23.06.2023 None Other Other EUR 24,971.13
23.06.2023 None Other Buy EUR 24,971.13
23.06.2023 None Other Buy EUR 23,193.00
23.06.2023 None Other Buy EUR 1,932.75
23.03.2023 None Other Sell EUR 1,650,415.80

Capital Markets Information

ISIN

FR0013280286

LEI

549300AK8Y0LBIQ4T071

Listed Stock Exchange

Euronext Paris

Stock Index

CAC Next 20

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.